The last defence? surgical aspects of gouty arthritis of hand and wrist

Hong Kong Medical Journal

Volumn 17, Issue 6, 2011, Pages 480-486

  Tang, Chris Y K ^a   Fung, Boris ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anti inflammatory agents; Antirheumatic agents; Gout surgery; Non steroidal; Prevalence

Indexed keywords

ALLOPURINOL; ANTICOAGULANT AGENT; COLCHICINE; COLCHICINE DERIVATIVE; CORTICOSTEROID; FEBUXOSTAT; NONSTEROID ANTIINFLAMMATORY AGENT; PROBENECID; URICOSURIC AGENT;

ARTHROCENTESIS; BONE DESTRUCTION; CLINICAL FEATURE; CRYSTALLOGRAPHY; DECOMPRESSION SURGERY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG MEGADOSE; GOUT; HAND; HUMAN; HYPERURICEMIA; IMMUNOGENICITY; INJURY; JOINT STABILITY; LEUKOCYTE COUNT; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MEDICAL RESEARCH; NEUROPATHY; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PREVALENCE; REVIEW; SURGICAL APPROACH; SURGICAL TECHNIQUE; SYNOVECTOMY; SYNOVIAL FLUID; SYSTEMATIC REVIEW; TEMPERATURE; TENOSYNOVECTOMY; TENOSYNOVITIS; WEIGHT REDUCTION; WRIST;

ARTHRITIS, GOUTY; HAND; HUMANS; WRIST;

EID: 83255176280     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Larmon WA, Kurtz JF. The surgical management of chronic tophaceous gout. J Bone Joint Surg Am 1958;40-A:743-72.
2. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005;64:267-72.
3. Lai SW, Liu CS, Lin T, Lin CC, Lai HC, Liao KF. Prevalence of gout and hyperuricemia in Taiwan: a hospital-based, crosssectional study. South Med J 2009;102:772-3.
4. Rott KT, Agudelo CA. Gout. JAMA 2003;289:2857-60.
5. Lin KC, Lin HY, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 2000;27:1501-5.
6. Wu XW, Muzny DM, Lee CC, Caskey CT. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol 1992;34:78-84.
7. Emmerson BT. Identification of the causes of persistent hyperuricaemia. Lancet 1991;337:1461-3.
8. Schumacher HR Jr. The pathogenesis of gout. Cleve Clin J Med 2008;75 Suppl 5:S2-4.
9. Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum 1972;15:189-92.
10. Martinon F, Glimcher LH. Gout: new insights into an old disease. J Clin Invest 2006;116:2073-5.
11. Yu KH, Ho HH, Chen JY, Luo SF. Gout complicated with necrotizing fasciitis-report of 15 cases. Rheumatology (Oxford) 2004;43:518-21.
12. Falasca GF. Metabolic diseases: gout. Clin Dermatol 2006;24:498-508.
13. Schlesinger N. Management of acute and chronic gouty arthritis: present state-of-the-art. Drugs 2004;64:2399-416.
14. Gerster JC, Landry M, Dufresne L, Meuwly JY. Imaging of tophaceous gout: computed tomography provides specific images compared with magnetic resonance imaging and ultrasonography. Ann Rheum Dis 2002;61:52-4.
15. Cassagrande PA. Surgery of tophaceous gout. Semin Arthritis Rheum 1971;1:262-73.
16. Poelzer C, Hildebrand KA. Gout of the wrist. J Am Soc Surg Hand 2004;4:256-65.
17. Linton RR, Talbott JH. The surgical treatment of tophaceous gout. Ann Surg 1943;117:161-82.
18. Mudgal CS. Management of tophaceous gout of the distal interphalangeal joint. J Hand Surg Br 2006;31:101-3.
19. Straub LR, Smith JW, Carpenter GK Jr, Dietz GH. The surgery of gout in the upper extremity. J Bone Joint Surg Am 1961;43:731-74.
20. Rich JT, Bush DC, Lincoski CJ, Harrington TM. Carpal tunnel syndrome due to tophaceous gout. Orthopedics 2004;27:862-3.
21. Phalen GS. The carpal-tunnel syndrome. Seventeen years' experience in diagnosis and treatment of six hundred fiftyfour hands. J Bone Joint Surg Am 1966;48:211-28.
22. Moore JR, Weiland AJ. Gouty tenosynovitis in the hand. J Hand Surg Am 1985;10:291-5.
23. Wurapa RK, Zelouf DS. Flexor tendon rupture caused by gout: a case report. J Hand Surg Am 2002;27:591-3.
24. Primm DD Jr, Allen JR. Gouty involvement of a flexor tendon in the hand. J Hand Surg Am 1983;8:863-5.
25. O'Connell PG, Milburn BM, Nashel DJ. Coexistent gout and septic arthritis: a report of two cases and literature review. Clin Exp Rheumatol 1985;3:265-7.
26. Schlesinger N, Detry MA, Holland BK, et al. Local ice therapy during bouts of acute gouty arthritis. J Rheumatol 2002;29:331-4.
27. Schlesinger N. Response to application of ice may help differentiate between gouty arthritis and other inflammatory arthritides. J Clin Rheumatol 2006;12:275-6.
28. Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 2010;62:1060-8.
29. Dorais J, Grégoire G, LeLorier J. Gastrointestinal damage associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1992;327:1882-3.
30. Sandler DP, Burr FR, Weinberg CR. Nonsteroidal antiinflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1991;115:165-72.
31. Scott JT. Management of gout. Br Med J 1969;3:456-7.
32. Gray RG, Tenenbaum J, Gottlieb NL. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum 1981;10:231-54.
33. Emmerson BT. The management of gout. N Engl J Med 1996;334:445-51.
34. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004;363:1277-81.
35. Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005;165:742-8.
36. Choi HK, Mount DB, Reginato AM; American College of Physicians; American Physiological Society. Pathogenesis of gout. Ann Intern Med 2005;143:499-516.
37. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2005;52:283-9.
38. Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;65:1312-24.
39. Whelton A. Current and future therapeutic options for the management of gout. Am J Ther 2010;17:402-17.
40. Takano Y, Hase-Aoki K, Horiuchi H, et al. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/ xanthine dehydrogenase. Life Sci 2005;76:1835-47.
41. Becker MA, Schumacher HR, Espinoza LR, et al. The uratelowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. Arthritis Res Ther 2010;12:R63.
42. Terkeltaub R, Zelman D, Scavulli J, Perez-Ruiz F, Lioté F. Gout Study Group: update on hyperuricemia and gout. Joint Bone Spine 2009;76:444-6.
43. Larmon WA. Surgical management of tophaceous gout. Clin Orthop Relat Res 1970;71:56-69.
44. Frankel JP, Boysen TJ, Ochwat GF. Surgery for tophaceous gout. J Foot Surg 1984;23:440-4.
45. Weniger FG, Davison SP, Risin M, Salyapongse AN, Manders EK. Gouty flexor tenosynovitis of the digits: report of three cases. J Hand Surg Am 2003;28:669-72.
46. Fitzgerald BT, Setty A, Mudgal CS. Gout affecting the hand and wrist. J Am Acad Orthop Surg 2007;15:625-35.
47. Wn K, Rl W. Gout and hyperuricaemia. In: Textbook of rheumatology. Philadelphia: WB Saunders Co; 1997: 1313-51.
48. Tripoli M, Falcone AR, Mossuto C, Moschella F. Different surgical approaches to treat chronic tophaceous gout in the hand: our experience. Tech Hand Up Extrem Surg 2010;14:187-90.
49. Lee SS, Sun IF, Lu YM, Chang KP, Lai CS, Lin SD. Surgical treatment of the chronic tophaceous deformity in upper extremities-the shaving technique. J Plast Reconstr Aesthet Surg 2009;62:669-74.
50. Gelberman RH, Doty DH, Hamer ML. Tophaceous gout involving the proximal interphalangeal joint. Clin Orthop Relat Res 1980;(147):225-7.
51. Vanwijck R, Kaba L, Boland S, Gonzales y Azero M, Delange A, Tourbach S. Immediate skin grafting of sub-acute and chronic wounds debrided by hydrosurgery. J Plast Reconstr Aesthet Surg 2010;63:544-9.
52. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen 2003;11 Suppl 1:S1-28.
53. Lee JH, Park JY, Seo JW, Oh DY, Ahn ST, Rhie JW. Surgical treatment of subcutaneous tophaceous gout. J Plast Reconstr Aesthet Surg 2010;63:1933-5.
54. Dalbeth N, Collis J, Gregory K, Clark B, Robinson E, McQueen FM. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford) 2007;46:1804-7.
55. Lee SS, Lin SD, Lai CS, Lin TM, Chang KP, Yang YL. The soft-tissue shaving procedure for deformity management of chronic tophaceous gout. Ann Plast Surg 2003;51:372-5.
56. Kumar S, Gow P. A survey of indications, results and complications of surgery for tophaceous gout. N Z Med J 2002;115:U109.